S
Stockadora

Ventyx Biosciences, Inc.

CIK: 0001851194

Company Information

Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 12790 EL CAMINO REAL, SUITE 200, SAN DIEGO, CA, 92130
Mailing Address 12790 EL CAMINO REAL, SUITE 200, SAN DIEGO, CA, 92130
Phone 7604076511
Fiscal Year End 1231
EIN 832996852

Financial Overview

FY2024

$353.89M
Stockholders' Equity
$-1.97
EPS

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13D/A Beneficial ownership amendment March 5, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
View all filings on EDGAR

Material Events

8-K Acquisition March 3, 2026
High Impact
  • Eli Lilly and Company will acquire Ventyx Biosciences, Inc. for approximately $750 million.
  • Ventyx shareholders will receive $15.00 per share in cash, providing a fixed payout and eliminating independent company risks.
View Analysis
8-K Acquisition February 23, 2026
High Impact
  • Eli Lilly and Company is acquiring Ventyx Biosciences, Inc. (VTYX) in an all-cash deal.
  • Ventyx shareholders will receive $14.00 in cash for each share, representing a significant premium over recent market valuation.
View Analysis
8-K Acquisition January 22, 2026
High Impact
  • Ventyx Biosciences is being acquired by pharmaceutical giant Eli Lilly and Company.
  • Special cash retention bonuses are approved for CEO Raju Mohan (up to $2,000,000) and other key executives to ensure a smooth transition and retain talent.
View Analysis

Insider Trading

SELL 2 insiders 2 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2834)

CAPRICOR THERAPEUTICS, INC.

CAPR Pharmaceutical Preparations

Inhibitor Therapeutics, Inc.

INTI Pharmaceutical Preparations

Adagene Inc.

ADAG Pharmaceutical Preparations

LFTD PARTNERS INC.

LIFD Pharmaceutical Preparations

CYTOKINETICS INC

CYTK Pharmaceutical Preparations

Investor Resources

Learn more about SEC filings and how to research public companies.

What is the SEC?

A plain English guide to the Securities and Exchange Commission

Understanding SEC Filings & CIK

How to navigate SEC filings and Central Index Keys

10-K Annual Reports Explained

Everything you need to know about annual reports

S-1 & F-1 IPO Filings

Understanding IPO registration statements

SEC EDGAR Database Guide

How to use the SEC's free filing database
Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.